The consistent response of fibroblasts (our data and [34,35,55]) to IGF-I might also help to explain the worse outcome of patients with elevated IGF-I levels in different cancer types [4-8], a finding that is not necessarily explained by the cancer cells themselves based on their IGF-receptor expression status on the cell surface. The gene discussed is IGF1; the disease is cancer.